MedMira Inc.
MMIRF · OTC
7/31/2024 | 7/31/2023 | 7/31/2022 | 7/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.87 | -0.41 | -0.28 | 1.69 |
| FCF Yield | -6.37% | -2.38% | -2.24% | -0.70% |
| EV / EBITDA | -30.58 | -39.71 | -89.48 | 505.30 |
| Quality | ||||
| ROIC | 30.36% | 33.75% | 39.22% | 4.56% |
| Gross Margin | 54.90% | 69.45% | 31.93% | 80.29% |
| Cash Conversion Ratio | 0.88 | 0.47 | 1.03 | 0.75 |
| Growth | ||||
| Revenue 3-Year CAGR | -24.33% | -41.35% | 1.18% | 59.61% |
| Free Cash Flow Growth | -190.07% | 35.04% | -261.00% | -29.54% |
| Safety | ||||
| Net Debt / EBITDA | -3.50 | -5.87 | -7.74 | 87.12 |
| Interest Coverage | -2.92 | 0.00 | -2.63 | -0.28 |
| Efficiency | ||||
| Inventory Turnover | 1.05 | 0.72 | 3.21 | 1.79 |
| Cash Conversion Cycle | -3,801.17 | -7,303.45 | -909.95 | -1,914.62 |